Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Congenital Hematological Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02996448
What this trial is testing

Safety, Tolerability, and Immunogenicity of One Dose of NDV 3A Vaccine in People With STAT3-Mutated Hyper-IgE Syndrome

Who this might be right for
Autosomal-dominant Hyper-IgE Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 3
Early research (Phase 1)Looking for participantsNCT06372717
What this trial is testing

Investigate APL-4098 Alone and in Combination in Adults With AML or MDS

Who this might be right for
Acute Myeloid Leukemia RefractoryMyelodysplastic Syndrome Acute Myeloid LeukemiaMyelodysplastic Syndrome With Excess Blasts+2 more
Apollo Therapeutics Ltd 100
Very early researchLooking for participantsNCT06565026
What this trial is testing

CS-206 in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
CorrectSequence Therapeutics Co., Ltd 5
Not applicableStudy completedNCT04451785
What this trial is testing

Hereditary Spherocytosis and Vascular Function

Who this might be right for
Hereditary Spherocytosis
Hospices Civils de Lyon 72
Not applicableStudy completedNCT07772050
What this trial is testing

IV Bevacizumab Treatment of Patients With Hereditary Hemorrhagic Telangiectasia (HHT) or Rendu-Osler (RO) Disease: A Retrospective Analysis of French Cohort Data From 2009 to 2024

Who this might be right for
Hereditary Hemorrhagic Telangiectasia (HHT)Rendu Osler Disease
Hospices Civils de Lyon 244
Not applicableStudy completedNCT04121247
What this trial is testing

Nonpharmacological Approaches and Parental Education in Children With Sickle Cell Disease

Who this might be right for
Nursing Caries
Akdeniz University 163
Early research (Phase 1)Study completedNCT01031368
What this trial is testing

Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+15 more
Nohla Therapeutics, Inc. 29
Not applicableStudy completedNCT03591640
What this trial is testing

The Validity of Kleinhauer Betke in Women With Known Hemoglobinopathy for Fetal-maternal Hemorrhage

Who this might be right for
Fetal-Maternal Hemorrhage
Hillel Yaffe Medical Center 27
Not applicableStudy completedNCT05450640
What this trial is testing

Satisfaction Regarding the Dispensing of Emicizumab (HEMLIBRA®) for Patients With Haemophilia A in France

Who this might be right for
Hemophilia A
Hospices Civils de Lyon 176
Early research (Phase 1)Study completedNCT02213250
What this trial is testing

An Open-Label, Single Dose Pharmacokinetic Study of Benefix (Recombinant Factor IX) in Male Chinese Subjects With Hemophilia B

Who this might be right for
Hemophilia B
Pfizer 12
Early research (Phase 1)Study completedNCT05169580
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pociredir

Who this might be right for
Sickle Cell DiseaseSickle Cell Anemia
Fulcrum Therapeutics 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT04853576
What this trial is testing

A Study Evaluating the Safety and Efficacy of EDIT-301 in Participants With Severe Sickle Cell Disease (RUBY)

Who this might be right for
Sickle Cell DiseaseHemoglobinopathies
Editas Medicine, Inc. 45
Testing effectiveness (Phase 2)Ended earlyNCT02002689
What this trial is testing

LDE225 for Patients With PTCH1 or SMO Mutated Tumors

Who this might be right for
PTCH1 or SMO Activated Solid and Hematologic Tumors
Novartis Pharmaceuticals 10
Not applicableStudy completedNCT02436213
What this trial is testing

Cardiopulmonary Exercise Testing to Evaluate Pulmonary AVMs

Who this might be right for
Pulmonary Arteriovenous MalformationsHereditary Hemorrhagic Telangiectasia
Imperial College London 39
Not applicableLooking for participantsNCT00230620
What this trial is testing

Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families

Who this might be right for
Telangiectasia, Hereditary Hemorrhagic
Imperial College London 1,000
Testing effectiveness (Phase 2)Ended earlyNCT02564796
What this trial is testing

Erythropoietin to Prevent Unnecessary Transfusions In Patients With Cyanotic CHD - A Prospective Control Trial

Who this might be right for
Cyanotic Congenital Heart DiseaseAnemiaCyanosis+1 more
University of California, San Diego 4
Not applicableEnded earlyNCT00260520
What this trial is testing

LMWH to Prevent Preeclampsia and Fetal Growth Restriction

Who this might be right for
Preeclampsia
University of Florence
Testing effectiveness (Phase 2)UnknownNCT00564759
What this trial is testing

Gene Therapy for Chronic Granulomatous Disease

Who this might be right for
Granulomatous Disease, Chronic
Johann Wolfgang Goethe University Hospital 2
Testing effectiveness (Phase 2)Study completedNCT03263559
What this trial is testing

Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507)

Who this might be right for
Sickle Cell Disease
Medical College of Wisconsin 95
Not applicableUnknownNCT03896997
What this trial is testing

Update in VWD Laboratory Diagnosis

Who this might be right for
VWD - Von Willebrand's Disease
Assiut University 100
Next Page